These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1836751)
1. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure]. Indolfi C; Piscione F; Volpe M; Lembo G; De Campora P; Russolillo E; Ambrosini V; Condorelli M; Chiariello M Cardiologia; 1991 May; 36(5):351-6. PubMed ID: 1836751 [TBL] [Abstract][Full Text] [Related]
2. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [TBL] [Abstract][Full Text] [Related]
3. [Effects of atrial natriuretic peptide on left ventricular function in man]. Indolfi C; Piscione F; Volpe M; Focaccio A; Trimarco B; Condorelli M; Chiariello M Cardiologia; 1989 Mar; 34(3):253-7. PubMed ID: 2525954 [TBL] [Abstract][Full Text] [Related]
4. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065 [TBL] [Abstract][Full Text] [Related]
5. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure. Ohte N; Cheng CP; Suzuki M; Little WC J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076 [TBL] [Abstract][Full Text] [Related]
6. Acute hemodynamic effects of intravenous nesiritide on left ventricular diastolic function in heart failure patients. Efstratiadis S; Michaels AD J Card Fail; 2009 Oct; 15(8):673-80. PubMed ID: 19786256 [TBL] [Abstract][Full Text] [Related]
7. Vasoactive peptides during long-term follow-up of patients after cardiac transplantation. Kirchhoff WCh; Gradaus R; Stypmann J; Deng MC; Tian TD; Scheld HH; Breithardt G; Brisse B J Heart Lung Transplant; 2004 Mar; 23(3):284-8. PubMed ID: 15019637 [TBL] [Abstract][Full Text] [Related]
8. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic correlates of atrial natriuretic peptide concentration in unselected patients with heart disease of different etiologies. La Vecchia L; Fortunato A; Varotto L; Bonanno C; Paccanaro M; Ometto R; Vincenzi M G Ital Cardiol; 1998 Dec; 28(12):1363-71. PubMed ID: 9887389 [TBL] [Abstract][Full Text] [Related]
10. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Sigurdsson A Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749 [TBL] [Abstract][Full Text] [Related]
11. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure. Mizuno O; Onishi K; Dohi K; Motoyasu M; Okinaka T; Ito M; Isaka N; Nakano T Am J Cardiol; 2001 Oct; 88(8):863-6. PubMed ID: 11676948 [TBL] [Abstract][Full Text] [Related]
12. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings. Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies. Randa Abdel Kader M; Grace BD; Badawi NE Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350 [TBL] [Abstract][Full Text] [Related]
14. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters]. Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099 [TBL] [Abstract][Full Text] [Related]
15. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. Kurnik BR; Weisberg LS; Cuttler IM; Kurnik PB J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949 [TBL] [Abstract][Full Text] [Related]
16. Plasma level of atrial natriuretic peptide as an indicator of increased cardiac load in uremic patients. Tikkanen I; Metsärinne K; Grönhagen-Riska C; Fyhrquist F Clin Nephrol; 1990 Oct; 34(4):167-72. PubMed ID: 2147876 [TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide during acute and prolonged exercise in well-trained men. Goodman JM; Logan AG; McLaughlin PR; Laprade A; Liu PP Int J Sports Med; 1993 May; 14(4):185-90. PubMed ID: 8325716 [TBL] [Abstract][Full Text] [Related]
18. Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure. Drexler H; Finkh M; Höing S; Toth M; Just H; Lang RE Basic Res Cardiol; 1987; 82(6):517-29. PubMed ID: 2963615 [TBL] [Abstract][Full Text] [Related]
19. [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness]. Grube E; Lauven GW; Manz M; Lüderitz B Dtsch Med Wochenschr; 1986 Mar; 111(11):416-20. PubMed ID: 3948703 [TBL] [Abstract][Full Text] [Related]
20. Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function. Indolfi C; Piscione F; Volpe M; Focaccio A; Lembo G; Trimarco B; Condorelli M; Chiariello M Am J Cardiol; 1989 Feb; 63(5):353-7. PubMed ID: 2521540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]